Dementia News and Research

Latest Dementia News and Research

New evidence shows older adults with dementia can be taken off antipsychotic medications

Most older adults with dementia can successfully be taken off antipsychotic medications, which have negative side effects and increase the risk of death, finds a new evidence review from The Cochrane Library.

29 Mar 2013

Study: Protein clumps in nerve cells are pathologies of Parkinson's disease

Clumps of α-synuclein protein in nerve cells are hallmarks of many degenerative brain diseases, most notably Parkinson's disease.

29 Mar 2013

New way to predict woman’s final menstrual period

A new UCLA-led study suggests a way to predict when a woman will have her final menstrual period. The findings, published in the April issue of the peer-reviewed Journal of Clinical Endocrinology and Metabolism, could help women and physicians gauge the onset of menopause-related bone loss, which generally begins a year prior to the last period.

28 Mar 2013

Navidea commences enrollment in NAV4694 Phase 2b study to detect erebral β-amyloid plaque

Navidea Biopharmaceuticals, Inc., a biopharmaceutical company focused on precision diagnostic radiopharmaceuticals, today announced that enrollment has commenced in its Phase 2b, open-label, safety and efficacy positron emission tomography imaging study of [18F]NAV4694 for detection of cerebral β-amyloid plaque in subjects diagnosed with Mild Cognitive Impairment.

28 Mar 2013

Molecular biologist hopes to learn why degenerative disorder affects specific brain cells

Dr. Santosh D'Mello, professor of molecular and cell biology at the University of Texas at Dallas, has received a federal grant for research that may shed light on why and how specific brain cells are affected by Huntington's disease, a devastating, degenerative brain disorder.

27 Mar 2013

Lundbeck, Otsuka reach agreement to develop and commercialize Lu AE58054

H. Lundbeck A/S and Otsuka Pharmaceutical Co., Ltd. today announced a license and development agreement for Lu AE58054, a selective 5HT6 receptor antagonist currently in development for the treatment of Alzheimer's disease.

26 Mar 2013

Two researchers awarded grants to develop indicators, biomarkers for dementia with Lewy bodies

The Lewy Body Dementia Association and the Alzheimer's Drug Discovery Foundation have awarded $100,000 each to Omar El-Agnaf, PhD, of United Arab Amirates University and Michelle Mielke, PhD, of Mayo Clinic Rochester to provide one year of support for their research projects focused on developing indicators, or biomarkers, for dementia with Lewy bodies.

26 Mar 2013

Norwegian study shows patients with Parkinson disease have increased risk for dementia

Mild cognitive impairment at the time of Parkinson disease diagnosis appears to be associated with an increased risk for early dementia in a Norwegian study, according to a report published Online First by JAMA Neurology, a JAMA Network publication.

26 Mar 2013

New education resource focuses on issues of sexual expression amongst people with dementia

Managing the delicate issue of sexual expression amongst people with dementia is the focus of a new education resource produced by Griffith University researcher Dr Cindy Jones.

24 Mar 2013

Cocaine can be lethal for people living with HIV

Cocaine, already a damaging drug for those with healthy immune systems, can be lethal for those living with human immunodeficiency virus. Mudit Tyagi, Ph.D., assistant professor of medicine at the George Washington University School of Medicine and Health Sciences, has received two federally funded grants to study how dangerous this combination is in HIV patients.

22 Mar 2013

Managing sexual expression among people with dementia

...

20 Mar 2013

Mayo Clinic neurology experts present research findings at AAN meeting

Mayo Clinic neurology experts will present research findings on Parkinson's disease, Alzheimer's disease, sleep disorders, concussions, multiple sclerosis and more at the American Academy of Neurology annual meeting in San Diego, March 16-23.

20 Mar 2013

New Alzheimer's data highlight the disease's deadly toll

According to figures released by the Alzheimer's Association, deaths from Alzheimer's and other forms of dementia rose 68 percent between 2000 and 2010.

20 Mar 2013

New research project on systems biology of synapse proteins and ageing launched

The AgedBrainSYSBIO project on systems biology of synapse proteins & ageing was officially launched March18th in Paris, France.

20 Mar 2013

Genetic testing services for rare neurological disorders launched by Athena Diagnostics

Athena Diagnostics, a leader in neurological diagnostics, today announced the clinical availability of new genetic tests to aid the detection of several rare neurological disorders, including hereditary neuropathy, neuromuscular disease, epilepsy and certain movement disorders. The lab-developed tests are available through Athena Diagnostics, a business of Quest Diagnostics (NYSE:DGX), the world’s leading provider of diagnostic information services.

From Quest Diagnostics 19 Mar 2013

Dementia diagnostic panel for treatable forms of cognitive impairment launched by Quest Diagnostics

Quest Diagnostics (NYSE: DGX), the world’s leading provider of diagnostic information services, announced the availability of the first clinical test panel for aiding the diagnosis of suspected dementia due to treatable forms of cognitive impairment. The test panel is believed to be the first commercial service from a clinical laboratory to combine several guideline-recommended tests for identifying secondary, treatable causes of dementia as a single blood test and report.

From Quest Diagnostics 19 Mar 2013

New report shows Alzheimer's deaths continue to rise in US

According to the Alzheimer's Association 2013 Alzheimer's Disease Facts & Figures report released today, one in three seniors dies with Alzheimer's or another dementia in the United States.

19 Mar 2013

First Edition: March 19, 2013

Today's headlines include coverage of a new report about the troubling reach of Alzheimer's disease.

19 Mar 2013

Viewpoints: Two views of Medicare equipment bidding changes; High Court case may impact FDA approval process

In 2010, Medicare spent more than $14 billion on oxygen devices, mobility scooters, diabetes test strips and other "durable medical equipment" and supplies that patients use at home.

19 Mar 2013

Controlling hypertension earlier in life may limit brain changes associated with Alzheimer's disease

A study in the JAMA Neurology (formerly the Archives of Neurology) suggests that controlling or preventing risk factors such as hypertension earlier in life may limit or delay the brain changes associated with Alzheimer's disease and other age-related neurological deterioration.

19 Mar 2013

Dementia News and Research

Latest Dementia News and Research

New evidence shows older adults with dementia can be taken off antipsychotic medications

Study: Protein clumps in nerve cells are pathologies of Parkinson's disease

New way to predict woman’s final menstrual period

Navidea commences enrollment in NAV4694 Phase 2b study to detect erebral β-amyloid plaque

Molecular biologist hopes to learn why degenerative disorder affects specific brain cells

Lundbeck, Otsuka reach agreement to develop and commercialize Lu AE58054

Two researchers awarded grants to develop indicators, biomarkers for dementia with Lewy bodies

Norwegian study shows patients with Parkinson disease have increased risk for dementia

New education resource focuses on issues of sexual expression amongst people with dementia

Cocaine can be lethal for people living with HIV

Managing sexual expression among people with dementia

Mayo Clinic neurology experts present research findings at AAN meeting

New Alzheimer's data highlight the disease's deadly toll

New research project on systems biology of synapse proteins and ageing launched

Genetic testing services for rare neurological disorders launched by Athena Diagnostics

Dementia diagnostic panel for treatable forms of cognitive impairment launched by Quest Diagnostics

New report shows Alzheimer's deaths continue to rise in US

First Edition: March 19, 2013

Viewpoints: Two views of Medicare equipment bidding changes; High Court case may impact FDA approval process

Controlling hypertension earlier in life may limit brain changes associated with Alzheimer's disease

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Dementia News and Research

Latest Dementia News and Research

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Newsletters you may be interested in